Legend Biotech Corporation
NASDAQ: LEGN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Ying Huang
- Employees
- 2,600
- Headquarters
- Somerset, United States
- IPO year
- 2020
- Market cap
- $5.2B
- Website
- https://www.legendbiotech.com
Loading LEGN…
Loading profile data…Frequently asked questions about LEGN
What does Legend Biotech Corporation (LEGN) do?
Legend Biotech Corporation is a clinical-stage biopharmaceutical firm, operating through its various subsidiaries, dedicated to the discovery and advancement of innovative cell therapies. These treatments primarily target oncological conditions but also address other diseases across the United States, China, and international markets. The compan...
Where does LEGN trade?
Legend Biotech Corporation (LEGN) trades on the NASDAQ Global Select.
What sector is LEGN in?
Legend Biotech Corporation (LEGN) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Legend Biotech Corporation?
Ying Huang is the chief executive officer of Legend Biotech Corporation (LEGN).
Where is Legend Biotech Corporation headquartered?
Legend Biotech Corporation is headquartered in United States.
Does LEGN pay a dividend?
Legend Biotech Corporation (LEGN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did LEGN go public?
Legend Biotech Corporation (LEGN) completed its initial public offering in 2020.
Is LEGN an ADR?
Yes — LEGN is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Legend Biotech Corporation reporting and dividends follow the underlying issuer.